Clinical Trials · NCT00961532

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

Name: Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Desmopressin

Phase: Phase 2
Recruitment status: Completed
Sponsor: Northwestern University
Enrollment: 14
Start date: Dec 2010
Locations: 1 site, United States
Primary endpoint: Change in Platelet Activity, Measured in Seconds on PFA-EPI Assay, From Pre to Post-treatment

View Desmopressin compound reference